Karen Yun • UCSD Profiles (original) (raw)
| | Title(s)Assistant Clinical Professor, MedicineSchoolVc-health Sciences-schoolsAddress9500 Gilman Drive #La Jolla CA 92093vCardDownload vCard | | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- |
Overview
Bibliographic
Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.)Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication.Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
- Circulating Biomarkers and Targeted Therapy in Pleural Mesothelioma. Cancers (Basel). 2025 Dec 01; 17(23). Grant CR, Bazhenova L, Yun KM. PMID: 41375064; PMCID: PMC12691059.
View in: PubMed Mentions: - Clinical factors and molecular co-alterations impact outcomes in patients receiving first-line osimertinib for EGFR-mutated non-small cell lung cancer. Lung Cancer. 2025 Oct; 208:108747. Sun F, Banwait MK, Singhal S, Herrmann A, Piotrowska Z, Yun K, Bazhenova L, Ullah AT, Guo EW, Wakelee HA, Neal JW, Das MS, Ramchandran KJ, Roy M, Diehn M, Myall NJ. PMID: 40957338; PMCID: PMC12937006.
View in: PubMed Mentions: Fields: - Emerging New Targets in Systemic Therapy for Malignant Pleural Mesothelioma. Cancers (Basel). 2024 Mar 22; 16(7). Yun KM, Bazhenova L. PMID: 38610930; PMCID: PMC11011044.
View in: PubMed Mentions: 5 - An Era of Advances in Systemic Therapies for Advanced Thyroid Cancer. JCO Oncol Pract. 2024 Jul; 20(7):899-906. Yun KM, Cohen EEW. PMID: 38452309.
View in: PubMed Mentions: 4 Fields:
Translation:Humans - Repotrectinib in a Patient With NTRK Fusion-Positive Pancreatic Carcinoma and Congenital Long QT Syndrome. JCO Precis Oncol. 2024 01; 8:e2300265. Yun KM, Narezkina A, Redfern C, Velasco K, Bazhenova L. PMID: 38271657; PMCID: PMC10830087.
View in: PubMed Mentions: 1 Fields:
Translation:Humans - Metastatic HER2-amplified non-small-cell lung cancer treated with trastuzumab deruxtecan. BMJ Case Rep. 2023 May 08; 16(5). Yun KM, Bazhenova L. PMID: 37156567; PMCID: PMC10173996.
View in: PubMed Mentions: 2 Fields:
Translation:Humans - Management of toxicities associated with immune checkpoint inhibitors. Clin Adv Hematol Oncol. 2023 Mar; 21(3):142-149. Yun KM, Bazhenova L. PMID: 36867558.
View in: PubMed Mentions: 2 Fields:
Translation:Humans - Immune Checkpoint Inhibitor Rechallenge After Prior Immune Toxicity. Curr Treat Options Oncol. 2022 09; 23(9):1153-1168. Bylsma S, Yun K, Patel S, Dennis MJ. PMID: 35876957; PMCID: PMC9402751.
View in: PubMed Mentions: 12 Fields:
Translation:Humans - Update on Lorlatinib: Role in Reducing the Risk of Disease Progression in ALK-Positive NSCLC. Cancer Manag Res. 2022; 14:843-850. Yun KM, Bazhenova LA. PMID: 35250311; PMCID: PMC8890401.
View in: PubMed Mentions: 4 - Rapid onset type 1 diabetes with anti-PD-1 directed therapy. Oncotarget. 2020 Jul 14; 11(28):2740-2746. Yun K, Daniels G, Gold K, Mccowen K, Patel SP. PMID: 32733645; PMCID: PMC7367652.
View in: PubMed Mentions: 10 Fields: - Women in Emergency Medicine Residency Programs: An Analysis of Data From Accreditation Council for Graduate Medical Education-approved Residency Programs. AEM Educ Train. 2017 Jul; 1(3):175-178. DeFazio CR, Cloud SD, Verni CM, Strauss JM, Yun KM, May PR, Lindstrom HA. PMID: 30051031; PMCID: PMC6001616.
View in: PubMed Mentions: 10
This graph shows the total number of publications by year. To see the data as text, click here.
This graph shows the total number of publications by year. To return to the graph, click here.
| Year | Publications |
|---|---|
| 2017 | 1 |
| 2020 | 1 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 3 |
| 2025 | 2 |
This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
Start with: newest oldestInclude: line numbers double spacing all authors publication IDs
Concepts (36)
Derived automatically from this person's publications.
_
Co-Authors (10)
People in Profiles who have published with this person.
_
Similar People (60)
People who share similar concepts with this person.
_
_